Computational Compound Prioritization Strategy Incorporating Docking Variability and Interaction Energies Identifies Putative LRH-1 Binders
Source check: Source checked. Not independent scientific confirmation.
Finding: ACS full article Results: prospective 98k compound prioritization, 95 compounds tested and four putative LRH-1 binders (4.2%); single-concentration pilot, no functional co-regulator validation. Claim kept to putative experimental binders. The result is reported in the Journal of Chemical Information and Modeling. It does not establish generalization beyond the reported setting or prospective real-world benefit.
Technology: ACS full article Results: prospective 98k compound prioritization, 95 compounds tested and four putative LRH-1 binders (4.2%)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- ACS full article Results: prospective 98k compound prioritization, 95 compounds tested and four putative LRH-1 binders (4.2%)
- Test and result
- ACS full article Results: prospective 98k compound prioritization, 95 compounds tested and four putative LRH-1 binders (4.2%); single-concentration pilot, no functional co-regulator validation. Claim kept to putative experimental binders.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pubs.acs.org/jcisd8/article/doi/10.1021/acs.jcim.6c02790/5466124/Computational-Compound-Prioritization-Strategy
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.